Cecily Williams Henson
About Cecily Williams Henson
Cecily Williams Henson is the Assistant General Counsel, Global Development Operations and Senior Corporate Counsel at Bristol Myers Squibb, with extensive experience in legal and regulatory compliance for global clinical trials.
Title and Current Role
Cecily Williams Henson currently serves as the Assistant General Counsel, Global Development Operations, and Senior Corporate Counsel at Bristol Myers Squibb in New Jersey, United States. In this role, she leads a team within the Patient, Data & Privacy Law group. She provides strategic legal, regulatory, and Good Clinical Practice (GCP) compliance advice related to the planning, execution, and management of global clinical trials, spanning from first-in-human studies to marketed products.
Professional Background and Previous Roles
Cecily Williams Henson spent 14 years at Hughes Hubbard & Reed LLP in New York, serving in various capacities including Counsel, Associate, and Summer Associate from 2002 to 2016. Before joining the legal profession, she worked in two different roles at the White House, serving as the Special Assistant to the President & Deputy Director of Presidential Scheduling, and as the Special Assistant to the Director of Intergovernmental Affairs.
Education and Legal Expertise
Cecily Williams Henson earned her Juris Doctor degree from the University of Michigan Law School. Prior to this, she obtained a Bachelor of Arts degree in Foreign Affairs and African American Studies from the University of Virginia. Additionally, she attended the National Cathedral School. Her extensive education has provided her with a solid foundation in legal and political affairs.
Responsibilities at Bristol Myers Squibb
At Bristol Myers Squibb, Cecily Williams Henson provides legal advice to a workforce of over 3000 employees across more than 40 countries. Her responsibilities include guiding research collaborations and managing investigator-sponsored research. Her role is critical in ensuring regulatory compliance and adherence to Good Clinical Practice (GCP) standards in global clinical trials.